Approach to Ascitic Fluid Analysis
Diagnostic paracentesis with comprehensive ascitic fluid analysis is essential for all patients with new-onset ascites, with specific testing determined by clinical context and pre-test probability of underlying conditions. 1
Initial Diagnostic Approach
Core Analysis (Required for All Patients)
- Serum-Ascites Albumin Gradient (SAAG): Differentiates portal hypertension (≥1.1 g/dL) from other causes (<1.1 g/dL) with 97% accuracy 1, 2
- Total protein concentration: Helps classify ascites type and evaluate SBP risk 1, 2
- Cell count with differential: Essential for diagnosing SBP (>250 neutrophils/mm³) 1, 2
- Bacterial culture: Inoculate directly into blood culture bottles at bedside to increase yield from ~50% to ~80% 1, 2
Interpretation of SAAG Results
- SAAG ≥1.1 g/dL: Indicates portal hypertension (cirrhosis, alcoholic hepatitis, heart failure)
- High protein (>2.5 g/dL): Suggests cardiac ascites
- Low protein (<2.5 g/dL): Suggests cirrhotic ascites
- SAAG <1.1 g/dL: Indicates non-portal hypertension causes (malignancy, tuberculosis, pancreatitis)
Targeted Additional Testing Based on Clinical Suspicion
For Suspected Malignancy
- Cytology: Send three samples for highest sensitivity (96.7%) 2
- Tumor markers: CEA, EpCAM, CA 15-3, CA 19-9 may increase positive predictive value 1
- Avoid CA-125: Non-specific and elevated in all types of ascites 2
For Suspected Tuberculosis
- Adenosine deaminase (ADA): Levels >40 IU/mL suggest TB; useful to distinguish from carcinomatosis 1
- Acid-fast bacilli smear and culture: Limited sensitivity (<50% culture positive, smear rarely positive) 1
For Suspected Pancreatic Ascites
- Amylase: Typically >1000 IU/L or >6× serum amylase in pancreatic ascites 1
For Suspected Secondary Bacterial Peritonitis
- Glucose: <50 mg/dL suggests secondary bacterial peritonitis 2
- LDH: Elevated in secondary bacterial peritonitis 2
- CEA: >5 ng/mL suggests gut perforation 2
- Alkaline phosphatase: >240 U/L suggests gut perforation 2
Specific Clinical Scenarios
When to Perform Diagnostic Paracentesis
- All patients with new-onset ascites 1
- Hospitalized cirrhotic patients with ascites at admission 1
- Patients with GI bleeding, shock, fever, signs of systemic inflammation 1
- Patients with worsening liver/renal function or hepatic encephalopathy 1
- Patients with abdominal pain or unexplained clinical deterioration 1
Management of Spontaneous Bacterial Peritonitis (SBP)
- Diagnosis: PMN count >250 cells/mm³ in ascitic fluid 1, 2
- Treatment: Immediate empirical antibiotic therapy (third-generation cephalosporins like cefotaxime) 1
- Follow-up: Repeat paracentesis at 48 hours to assess treatment response 1
- Special consideration: Patients with SBP and signs of renal impairment should receive albumin (1.5 g/kg in first 6 hours) 1
Culture-Negative Neutrocytic Ascites vs. Bacterascites
- Culture-negative neutrocytic ascites: PMN >250/mm³ but negative culture; treat as SBP 1
- Bacterascites: Positive culture but PMN <250/mm³; may represent transient colonization or early SBP 1
- For symptomatic patients: Treat as early SBP
- For asymptomatic patients: Consider repeat paracentesis to guide management 1
Common Pitfalls to Avoid
Delaying paracentesis due to coagulopathy concerns: Paracentesis is safe even with abnormal coagulation parameters; prophylactic fresh frozen plasma or platelets are not routinely needed 1, 2
Inadequate culture technique: Always inoculate fluid directly into blood culture bottles at bedside to maximize diagnostic yield 1, 2
Over-reliance on CA-125: This marker is elevated in all types of ascites and may lead to unnecessary gynecologic procedures 2
Missing secondary bacterial peritonitis: Consider this diagnosis when there are localized abdominal symptoms, very high neutrophil count, multiple organisms on culture, or inadequate response to antibiotics 1
Failure to recognize bacterascites in symptomatic patients: This may represent early SBP and requires treatment 1
Neglecting to repeat paracentesis after 48 hours of treatment: Important to confirm response to therapy, especially when clinical improvement is not evident 1
By following this systematic approach to ascitic fluid analysis, clinicians can efficiently diagnose the underlying cause of ascites and initiate appropriate management to reduce morbidity and mortality.